March 11, 2026

Many Titles, One Mission: Advancing Team-Based Care in Oncology

The ACP insists on using 'physician' over 'provider' to uphold the integrity of the healthcare system amidst growing physician shortages.

JADPRO

March 04, 2026

Advanced Practice Providers in Oncology Care: Consensus Principles for Clinical Practice Utilization

Discover how the integration of advanced practice providers in oncology is evolving and the principles that guide their essential roles in patient care. Source: NCCN.

JADPRO

March 04, 2026

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance

Explore the multifaceted case of Ms. Jones, a 54-year-old woman navigating her diagnosis of MGUS and the complexities of treatment decisions.

JADPRO

March 04, 2026

Characterizing the Clinical Role of Radiation Oncology Advanced Practice Providers Using Entrustable Professional Activities

A study highlights the evolving role of advanced practice providers in radiation oncology, revealing gaps in training and the potential for improved patient care.

JADPRO

March 04, 2026

Black Patients With AML Face Younger Onset and Significantly Worse Survival Outcomes

A new analysis spanning more than 3 decades of Eastern Cooperative Oncology Group and American College of Radiology Imaging Network (ECOG-ACRIN) clinical trial data demonstrates that Black patients wi...

The ASCO Post

March 03, 2026

Miami Cancer Institute Leads Landmark Phase 2 Glioblastoma Trial

The randomized Phase 2 CRUX-2 trial (Ruxolitinib in Combination with Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma) is currently recruiting.

Baptist Health South Florida

February 27, 2026

Latest Clinical Evidence in Extensive-Stage Small Cell Lung Cancer Treatment

Discover the latest strategies in the treatment and management of extensive-stage small cell lung cancer, emphasizing the critical role of supportive care and advancements in therapy. - JADPRO Live.

JADPRO

February 27, 2026

Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer

Explore the latest insights on treating metastatic triple-positive breast cancer, emphasizing multimodal therapy and adverse event management, as discussed by oncology experts at JADPRO Live 2025.

JADPRO

February 20, 2026

Epcoritamab Plus R² in Follicular Lymphoma: A Potential New Treatment Standard

In patients with follicular lymphoma who received at least one prior line of therapy, the combination of the bispecific antibody epcoritamab-bysp and rituximab–lenalidomide (R2) reduced the risk of di...

The ASCO Post

February 15, 2026

Dana-Farber Research News 02.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from January 16 - 31.

Dana-Farber